• SUBSCRIBE
    • Action Alerts PLUS
    • Real Money
    • Real Money Pro
    • Quant Ratings
    • Retirement Daily
    • Stocks Under $10
    • Trifecta Stocks
    • Top Stocks
    • Real Money Pro Portfolio
    • Chairman's Club
    • Compare All
  • JIM CRAMER
    • Action Alerts PLUS
    • Cramer's Blog
    • Cramer's Monthly Call
    • Jim Cramer's Best Stocks
    • Cramer's Articles
    • Mad Money
    • 25 Rules for Investing
    • 10 Commandments
  • INVESTING
    • Bitcoin
    • Cannabis
    • Cryptocurrency
    • ETFs
    • Earnings
    • Fixed Income
    • Funds
      • Bond Funds
      • Index Funds
      • Mutual Funds
    • Futures
    • Options
    • REITs
    • Stocks
      • Penny Stocks
      • Preferred Stocks
  • PERSONAL FINANCE
    • Credit Cards
    • Debt Management
    • Education
    • Employee Benefits
    • Insurance
      • Car Insurance
      • Disability Insurance
      • Health Insurance
      • Home Insurance
      • Life Insurance
    • Mortgages
    • Real Estate
    • Savings
    • Taxes
  • RETIREMENT
    • 401K
    • Estate Planning
    • IRAs
      • Roth IRAs
    • Social Security
  • TECHNOLOGY
    • Cybersecurity
  • MARKETS
    • Bankruptcy
    • Commodities
      • Gold
      • Oil
    • Corporate Governance
    • Currencies
    • Emerging Markets
    • IPOs
    • Mergers and Acquisitions
    • Rates and Bonds
      • Junk Bonds
      • Treasury Bonds
    • Regulation
  • HOW-TO
  • VIDEO
    • Audio
  • Courses
    • Personal Finance Essentials
    • Fundamentals of Investing
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
  • Privacy Settings
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account
TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
  • Alerts
  • |
  • Newsletters
  • Logo
  • JIM CRAMER
  • INVESTING
  • PERSONAL FINANCE
  • RETIREMENT
  • TECHNOLOGY
  • MARKETS
  • HOW-TO
  • VIDEO
  • COURSES
Login
Account

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Avoid the 'Spring Slump' With These 4 Big, Outperforming Stocks
MERGERS AND ACQUISITIONS

Johnson & Johnson Looks for New Deal That's Just Right

  • By Alicia McElhaney
  • Dec 15, 2016 7:30 AM EST
Amicus Shares Barely Budge on Prediction of $3 Billion Buyout
STOCKS

The Nominees for Best Biopharma CEO of 2015 Are...

  • By Adam Feuerstein
  • Dec 15, 2015 8:14 AM EST
Jim Cramer's 'Mad Money' Recap: Here's What I'm Watching Next Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: Here's How Oil, the Fed and China Pushed Markets Up

  • By Scott Rutt
  • Aug 27, 2015 8:22 PM EDT
Denbury Resources (DNR) Stock Drops on Falling Oil Prices
MARKETS

AbbVie (ABBV) Stock Price Target Raised at Deutsche Bank

  • By Eiffy Luo
  • Jul 29, 2015 11:20 AM EDT
Citigroup (C) Stock Higher Today After Earnings Beat
MARKETS

AbbVie (ABBV) Stock Gains After IMBRUVICA Receives EU Regulatory Approval

  • By Tony Owusu
  • Jul 10, 2015 3:37 PM EDT
Amgen Takes $2.7 Billion Stake in BeiGene to Expand Access to China
INVESTING

AXON, REGN, BURL, FIVE: Jim Cramer's Views

  • By Jim Cramer
  • Jun 15, 2015 1:00 AM EDT
Weatherford Int'l. (WFT) Stock Sliding Amid Lower Oil Prices
MARKETS

AbbVie (ABBV) Stock Gains on Bullish JPMorgan Note

  • By Tony Owusu
  • May 27, 2015 11:42 AM EDT
As the Trump Rally Resumes, Buy This Battered Health Sector Blue-Chip
INVESTING

Jim Cramer -- Here's Why I'm Buy, Buy, Buying J&J and Selling Merck

  • By Jim Cramer
  • May 26, 2015 2:27 PM EDT
What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

AbbVie (ABBV) Stock Gains After Completing $21 Billion Pharmacyclics Purchase

  • By Tony Owusu
  • May 26, 2015 12:42 PM EDT
Cramer: I'm Buying J&J as It Has the Most Upside of Major Pharmas
VIDEO

Cramer: I'm Buying J&J as It Has the Most Upside of Major Pharmas

  • By Jim Cramer
  • May 26, 2015 12:34 PM EDT
Insider Trading Alert - AEL, ANIP And CRM Traded By Insiders
MARKETS

New Lifetime High For Pharmacyclics (PCYC)

  • By TheStreet Wire
  • May 22, 2015 9:46 AM EDT
Stock Market Today - Corporate Profitability Trends, Global Marco Economy
INVESTING

Jim Cramer -- Stock Market's Takeover Frenzy Won't End Anytime Soon

  • By Jim Cramer
  • May 19, 2015 9:34 AM EDT
A Guide to Future Fed Decisions and You
INVESTING

Jim Cramer -- Why Is Janet Yellen Suddenly a Stock Commentator?

  • By Jim Cramer
  • May 7, 2015 9:01 AM EDT
AbbVie Falls After Missing Top- and Bottom-Line Estimates
MERGERS AND ACQUISITIONS

AbbVie Refiles for Antitrust Review of Pharmacyclics Deal

  • By Scott Stuart
  • Apr 20, 2015 7:12 PM EDT
Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Johnson & Johnson (JNJ) Stock Climbing Today on Better Than Expected First Quarter Earnings

  • By Kurumi Fukushima
  • Apr 14, 2015 8:37 AM EDT
Continental Resources (CLR) Stock Rises Today as Oil Prices Rally
MARKETS

What to Expect When Johnson & Johnson (JNJ) Reports First-Quarter Earnings Tomorrow

  • By Andrew Meola
  • Apr 13, 2015 3:17 PM EDT
Dick's Sporting Goods (DKS) Stock Declines Pre-Market on Weak First Quarter SSS
MARKETS

AbbVie (ABBV) Stock Opens Higher, Then Falls Today Following Analyst Upgrade

  • By Andrew Meola
  • Apr 13, 2015 1:36 PM EDT
Stock Building Supply Merger Creates a $1.5 Billion Company
MERGERS AND ACQUISITIONS

First-Quarter Deals Near $1 Trillion Mark Highest Value Since 2007

  • By Jaewon Kang
  • Apr 13, 2015 11:47 AM EDT
Immunogen Tanks After Ovarian Cancer Drug Study Fails to Meet Endpoint
INVESTING

Jim Cramer -- Mylan's Move to Acquire Perrigo a Prescription for Success

  • By Jim Cramer
  • Apr 9, 2015 7:00 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
INVESTING

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

  • By Adam Feuerstein
  • Mar 30, 2015 10:43 AM EDT
Join Jim Cramer and Jack Mohr for Exclusive Market Update
INVESTING

Biotech, Chips Stand Their Ground; Be Careful What You Wish For: Jim Cramer's Best Blogs

  • By Jim Cramer
  • Mar 28, 2015 3:19 PM EDT
Touch Technology Provider's Shares on the Rise
INVESTING

BioMarin Rises Amid Takeover Speculation, Price Target Raises

  • By The Fly Staff
  • Mar 27, 2015 10:37 AM EDT
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

3 Stocks Reiterated As A Hold: PCYC, LNKD, PM

  • By Subhi Syed
  • Mar 26, 2015 10:51 AM EDT
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab
STOCKS

Biotech Stocks Are Selling Off Just Like 2014 -- and That Might Be a Good Thing

  • By Adam Feuerstein
  • Mar 26, 2015 7:17 AM EDT
Jim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care Strength
INVESTING

Jim Cramer Digs Into Dozens of Charts, Finds 7 Pillars of Health Care Strength

  • By Jim Cramer
  • Mar 23, 2015 2:18 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2019 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.